IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence()()

Head and neck squamous cell carcinomas (HNSCC) exhibit a small population of uniquely tumorigenic cancer stem cells (CSC) endowed with self-renewal and multipotency. We have recently shown that IL-6 enhances the survival and tumorigenic potential of head and neck cancer stem cells (i.e. ALDH(high)CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Finkel, Kelsey A., Warner, Kristy A., Kerk, Samuel, Bradford, Carol R., McLean, Scott A., Prince, Mark E., Zhong, Haihong, Hurt, Elaine M., Hollingsworth, Robert E., Wicha, Max S., Tice, David A., Nör, Jacques E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887598/
https://www.ncbi.nlm.nih.gov/pubmed/27237319
http://dx.doi.org/10.1016/j.neo.2016.03.004

Ejemplares similares

Ejemplares similares